{"entity":{"type":"insider","cik":"0001670740","url":"/insider/0001670740","json_url":"/insider/0001670740.json","name":"Orford Keith","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":13,"first":"2017-07-19","last":"2021-11-12","span_basis":"filed_date"},"name_variants":[{"name":"Orford Keith","source":"filing","n_filings":13,"first_seen":"2017-07-19","last_seen":"2021-11-12"}],"transactions":[{"id":5395827,"accession":"0000899243-21-044426","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-044426","line_url":"/filing/0000899243-21-044426#line-2","is_derivative":false,"issuer_cik":"0001496671","issuer_name":"Calithera Biosciences, Inc.","issuer_ticker":"CALA","issuer_name_source":null,"issuer_url":"/issuer/0001496671","owner_cik":"0001670740","owner_name":"Orford Keith","owner_display_name":"Orford Keith","owner_url":"/insider/0001670740","role":"Officer (Director)","role_mark":"O","role_mark_label":"Officer (Director)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Director","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48190.0,"shares_display":"48,190","price_per_share":0.88,"price_display":"0.88","price_state":"stated","total_value":42407.2,"total_display":"42,407.20","total_whole":"42,407","shares_owned_after":66094.0,"shares_owned_after_display":"66,094","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-11","filed_date":"2021-11-12","scope":"insider"},{"id":5395824,"accession":"0000899243-21-044426","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-044426","line_url":"/filing/0000899243-21-044426#line-1","is_derivative":false,"issuer_cik":"0001496671","issuer_name":"Calithera Biosciences, Inc.","issuer_ticker":"CALA","issuer_name_source":null,"issuer_url":"/issuer/0001496671","owner_cik":"0001670740","owner_name":"Orford Keith","owner_display_name":"Orford Keith","owner_url":"/insider/0001670740","role":"Officer (Director)","role_mark":"O","role_mark_label":"Officer (Director)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Director","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":0.8565,"price_display":"0.86","price_state":"stated","total_value":25695.0,"total_display":"25,695.00","total_whole":"25,695","shares_owned_after":114284.0,"shares_owned_after_display":"114,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-10","filed_date":"2021-11-12","scope":"insider"},{"id":4267864,"accession":"0000899243-21-043693","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-043693","line_url":"/filing/0000899243-21-043693#line-2","is_derivative":false,"issuer_cik":"0001496671","issuer_name":"Calithera Biosciences, Inc.","issuer_ticker":"CALA","issuer_name_source":null,"issuer_url":"/issuer/0001496671","owner_cik":"0001670740","owner_name":"Orford Keith","owner_display_name":"Orford Keith","owner_url":"/insider/0001670740","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51810.0,"shares_display":"51,810","price_per_share":0.84,"price_display":"0.84","price_state":"stated","total_value":43520.4,"total_display":"43,520.40","total_whole":"43,520","shares_owned_after":144284.0,"shares_owned_after_display":"144,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-09","filed_date":"2021-11-09","scope":"insider"},{"id":3033689,"accession":"0000899243-20-034490","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-034490","line_url":"/filing/0000899243-20-034490#line-1","is_derivative":false,"issuer_cik":"0001496671","issuer_name":"Calithera Biosciences, Inc.","issuer_ticker":"CALA","issuer_name_source":null,"issuer_url":"/issuer/0001496671","owner_cik":"0001670740","owner_name":"Orford Keith","owner_display_name":"Orford Keith","owner_url":"/insider/0001670740","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2447.0,"shares_display":"2,447","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":14682.0,"total_display":"14,682.00","total_whole":"14,682","shares_owned_after":11094.0,"shares_owned_after_display":"11,094","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-16","filed_date":"2020-12-18","scope":"insider"},{"id":2039552,"accession":"0000899243-20-005595","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-005595","line_url":"/filing/0000899243-20-005595#line-1","is_derivative":false,"issuer_cik":"0001496671","issuer_name":"Calithera Biosciences, Inc.","issuer_ticker":"CALA","issuer_name_source":null,"issuer_url":"/issuer/0001496671","owner_cik":"0001670740","owner_name":"Orford Keith","owner_display_name":"Orford Keith","owner_url":"/insider/0001670740","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3021.0,"shares_display":"3,021","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":24168.0,"total_display":"24,168.00","total_whole":"24,168","shares_owned_after":8541.0,"shares_owned_after_display":"8,541","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-20","filed_date":"2020-02-24","scope":"insider"},{"id":7910238,"accession":"0000899243-19-030045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-030045","line_url":"/filing/0000899243-19-030045#line-1","is_derivative":false,"issuer_cik":"0001496671","issuer_name":"Calithera Biosciences, Inc.","issuer_ticker":"CALA","issuer_name_source":null,"issuer_url":"/issuer/0001496671","owner_cik":"0001670740","owner_name":"Orford Keith","owner_display_name":"Orford Keith","owner_url":"/insider/0001670740","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3021.0,"shares_display":"3,021","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":18126.0,"total_display":"18,126.00","total_whole":"18,126","shares_owned_after":11562.0,"shares_owned_after_display":"11,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-23","filed_date":"2019-12-26","scope":"insider"},{"id":8186713,"accession":"0000899243-19-017412","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-017412","line_url":"/filing/0000899243-19-017412#line-1","is_derivative":false,"issuer_cik":"0001496671","issuer_name":"Calithera Biosciences, Inc.","issuer_ticker":"CALA","issuer_name_source":null,"issuer_url":"/issuer/0001496671","owner_cik":"0001670740","owner_name":"Orford Keith","owner_display_name":"Orford Keith","owner_url":"/insider/0001670740","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":417.0,"shares_display":"417","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":2502.0,"total_display":"2,502.00","total_whole":"2,502","shares_owned_after":12083.0,"shares_owned_after_display":"12,083","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-17","filed_date":"2019-06-19","scope":"insider"},{"id":8273198,"accession":"0000899243-19-014707","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-014707","line_url":"/filing/0000899243-19-014707#line-1","is_derivative":false,"issuer_cik":"0001496671","issuer_name":"Calithera Biosciences, Inc.","issuer_ticker":"CALA","issuer_name_source":null,"issuer_url":"/issuer/0001496671","owner_cik":"0001670740","owner_name":"Orford Keith","owner_display_name":"Orford Keith","owner_url":"/insider/0001670740","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":416.0,"shares_display":"416","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":2496.0,"total_display":"2,496.00","total_whole":"2,496","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-22","filed_date":"2019-05-24","scope":"insider"},{"id":8437126,"accession":"0000899243-19-010747","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-010747","line_url":"/filing/0000899243-19-010747#line-1","is_derivative":false,"issuer_cik":"0001496671","issuer_name":"Calithera Biosciences, Inc.","issuer_ticker":"CALA","issuer_name_source":null,"issuer_url":"/issuer/0001496671","owner_cik":"0001670740","owner_name":"Orford Keith","owner_display_name":"Orford Keith","owner_url":"/insider/0001670740","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":416.0,"shares_display":"416","price_per_share":6.33,"price_display":"6.33","price_state":"stated","total_value":2633.28,"total_display":"2,633.28","total_whole":"2,633","shares_owned_after":10416.0,"shares_owned_after_display":"10,416","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-15","filed_date":"2019-04-17","scope":"insider"},{"id":8690591,"accession":"0000899243-19-008333","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-008333","line_url":"/filing/0000899243-19-008333#line-1","is_derivative":false,"issuer_cik":"0001496671","issuer_name":"Calithera Biosciences, Inc.","issuer_ticker":"CALA","issuer_name_source":null,"issuer_url":"/issuer/0001496671","owner_cik":"0001670740","owner_name":"Orford Keith","owner_display_name":"Orford Keith","owner_url":"/insider/0001670740","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":417.0,"shares_display":"417","price_per_share":6.43,"price_display":"6.43","price_state":"stated","total_value":2681.31,"total_display":"2,681.31","total_whole":"2,681","shares_owned_after":10832.0,"shares_owned_after_display":"10,832","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-15","filed_date":"2019-03-19","scope":"insider"},{"id":8114879,"accession":"0000899243-19-007526","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-007526","line_url":"/filing/0000899243-19-007526#line-1","is_derivative":false,"issuer_cik":"0001496671","issuer_name":"Calithera Biosciences, Inc.","issuer_ticker":"CALA","issuer_name_source":null,"issuer_url":"/issuer/0001496671","owner_cik":"0001670740","owner_name":"Orford Keith","owner_display_name":"Orford Keith","owner_url":"/insider/0001670740","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1565.0,"shares_display":"1,565","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":9390.0,"total_display":"9,390.00","total_whole":"9,390","shares_owned_after":11249.0,"shares_owned_after_display":"11,249","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-11","filed_date":"2019-03-13","scope":"insider"},{"id":6647223,"accession":"0000899243-18-026882","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-026882","line_url":"/filing/0000899243-18-026882#line-1","is_derivative":false,"issuer_cik":"0001496671","issuer_name":"Calithera Biosciences, Inc.","issuer_ticker":"CALA","issuer_name_source":null,"issuer_url":"/issuer/0001496671","owner_cik":"0001670740","owner_name":"Orford Keith","owner_display_name":"Orford Keith","owner_url":"/insider/0001670740","role":"Officer (SR. VP, CLINICAL DEVELOPMENT)","role_mark":"O","role_mark_label":"Officer (SR. VP, CLINICAL DEVELOPMENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR. VP, CLINICAL DEVELOPMENT","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":313.0,"shares_display":"313","price_per_share":6.05,"price_display":"6.05","price_state":"stated","total_value":1893.65,"total_display":"1,893.65","total_whole":"1,894","shares_owned_after":10314.0,"shares_owned_after_display":"10,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-15","filed_date":"2018-10-17","scope":"insider"},{"id":6514291,"accession":"0000899243-18-026708","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-026708","line_url":"/filing/0000899243-18-026708#line-1","is_derivative":false,"issuer_cik":"0001496671","issuer_name":"Calithera Biosciences, Inc.","issuer_ticker":"CALA","issuer_name_source":null,"issuer_url":"/issuer/0001496671","owner_cik":"0001670740","owner_name":"Orford Keith","owner_display_name":"Orford Keith","owner_url":"/insider/0001670740","role":"Officer (SR. VP, CLINICAL DEVELOPMENT)","role_mark":"O","role_mark_label":"Officer (SR. VP, CLINICAL DEVELOPMENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR. VP, CLINICAL DEVELOPMENT","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1252.0,"shares_display":"1,252","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":7512.0,"total_display":"7,512.00","total_whole":"7,512","shares_owned_after":10627.0,"shares_owned_after_display":"10,627","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-11","filed_date":"2018-10-15","scope":"insider"},{"id":4691354,"accession":"0000899243-17-018550","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-018550","line_url":"/filing/0000899243-17-018550#line-1","is_derivative":false,"issuer_cik":"0001496671","issuer_name":"Calithera Biosciences, Inc.","issuer_ticker":"CALA","issuer_name_source":null,"issuer_url":"/issuer/0001496671","owner_cik":"0001670740","owner_name":"Orford Keith","owner_display_name":"Orford Keith","owner_url":"/insider/0001670740","role":"Officer (SR. VP, CLINICAL DEVELOPMENT)","role_mark":"O","role_mark_label":"Officer (SR. VP, CLINICAL DEVELOPMENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR. VP, CLINICAL DEVELOPMENT","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2120.0,"shares_display":"2,120","price_per_share":18.3126,"price_display":"18.31","price_state":"stated","total_value":38822.712,"total_display":"38,822.71","total_whole":"38,823","shares_owned_after":6879.0,"shares_owned_after_display":"6,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-17","filed_date":"2017-07-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001496671","name":"Calithera Biosciences, Inc.","url":"/issuer/0001496671","role":"Director, Officer (Director)","n_filings":13,"first_seen":"2017-07-19","last_seen":"2021-11-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001670740","retrieved_at":"2026-08-27T13:32:23+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}